Business Wire

LUOHAN-ACADEMY

24.1.2019 15:10:10 CET | Business Wire | Press release

Share
Luohan Academy Unveils Report on Digital Technology and Inclusive Growth at World Economic Forum

Luohan Academy – an open research institute initiated by Alibaba Group Holding Limited (NYSE: BABA) – today released its first report examining the oft-debated relationship between digital technology and economic growth at the 2019 World Economic Forum in Davos. The report demonstrates how digital technology can drive inclusive growth in ways previous technology revolutions have not, especially when policies and public-private sector cooperation are supportive.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190124005445/en/

The report was launched at an event co-hosted with the World Bank, and featured speeches and discussions with high-profile experts, including Her Majesty Queen Máxima of the Netherlands and the UN Secretary-General's Special Advocate for Inclusive Finance for Development (UNSGSA); Kristalina Georgieva, CEO of the World Bank; Michael Spence, Professor of Economics at New York University and Nobel Prize Winner; Jack Ma, Alibaba Group Executive Chairman; and Chen Long, Director of Luohan Academy. More than 120 delegates from the World Economic Forum attended the launch event, including government officials, chief executives, academics, and heads of NGOs, international organizations and development agencies.

The report “Digital Technology and Inclusive Growth ” details why the benefits of the current digital revolution can be more evenly distributed than they were in previous technological revolutions. At the macro level, widespread adoption and application of digital technology is no longer dependent on level of income and economic development. At the micro level, digital technology is making it easier for consumers to start businesses, reach consumers, and access financing. Using China as a case study, the report illustrates how digital technologies can provide more access to economic opportunity in ways not possible previously.

“Experience in China and other emerging markets shows the tremendous potential of a new growth path, one that makes development more inclusive and sustainable,” said Chen Long, Director of Luohan Academy. “With public-private joint efforts and the right policies, the digital age presents new opportunities for emerging markets that did not exist before.”

This report identifies where digital technologies have made a material difference for inclusive growth in China, and offers some insights on how to apply the lessons learned in China to other markets. Some key findings include:

  • Lowering the skill threshold: In order to promote digital penetration, lowering the skill threshold needed to use technology is as important as raising the level of technological expertise. For example, in rural Taobao villages in China, e-tailer households that participate in e-commerce earn more than double the income of non-e-tailer households at every education level because the skills can be learned on the job; no formal education required.
  • Leveraging digital platforms: Digital platforms represent a new form of exchange and coordination to create an ecosystem for inclusive growth. It is a free-spinning wheel that connects numerous consumers and producers, and facilities interactions with very low cost, high efficiency, and reliability.
  • Forming effective public-private partnerships: It is more important than ever for the public sector to create a benign macro environment for the private sector to grow and make necessary investments for the population to access digital technology.
  • Managing unanticipated effects: In the digital age, there have been concerns about real and complex issues such as technological unemployment, abuse of private information, lagging competition policy, and increased inequality. The first step to address these challenges is to separate facts from speculation and anxiety. The evidence in China shows that the benefits of new market access and opportunities are more pronounced in less developed countries.

“This report on digitally enabled growth patterns in China is very interesting. The data shows that the mobile internet, e-commerce, mobile payments and internet-based financial services together have accelerated overall growth and produced startlingly inclusive growth patterns in multiple dimensions. The report documents this, and explains why these effects occur,” said Michael Spence, 2001 Nobel Prize Laureate in Economics and professor at New York University. “In conjunction with gained experience in other developing countries, there is a very convincing case that digitally-enabled, platform-based ecosystems are a new and powerful growth engine.”

Launched in June 2018 in Hangzhou, the Luohan Academy is focused on addressing universal challenges that arise from the rapid development of digital technologies. With 16 Nobel Prize laureates and prominent academics as committee members, the institute aims at bringing together the top scholars in the world to study the most pressing issues of the digital economy and advance the research of technology and its impact on humanity.

About Luohan Academy

Luohan Academy, an independent think tank and open research institute, was initiated by Alibaba Group on 26th June, 2018 in Hangzhou, China. It was launched by Jack Ma, Alibaba's founder and Executive Chairman, and 16 academic committee members. Luohan Academy intends to bring together the best thinkers in the world with first-hand practical insights into the digital economy in order to advance the research frontiers of digital technology and its impact on humanity. Its mission is two-fold: to understand how digital technology can help achieve common good; and to build a broad research community for systematic and in-depth learning, leading to new paradigms for solving the most pressing issues in digital society.

Contact:

Media: Holly Zhao Holly.zhao@alibaba-inc.com +1 (505) 469-3316

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye